Negin Hatami
Overview
Explore the profile of Negin Hatami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hatami N, Malekpour M, Farzadfar F, Seyedifar M, Soleymani F
Daru
. 2023 Oct;
31(2):259-266.
PMID: 37848743
Background: Diabetes Mellitus (DM) is a prominent health care issue worldwide. One of the most prevalent comorbidities of DM is cardiovascular disease (CVD). The objective of this study was to...
2.
Wardak M, Sonni I, Fan A, Minamimoto R, Jamali M, Hatami N, et al.
Radiology
. 2022 Feb;
303(3):620-631.
PMID: 35191738
Background The PET tracer (4S)-4-(3-[F]fluoropropyl)-l-glutamate (F-FSPG) targets the system x cotransporter, which is overexpressed in various tumors. Purpose To assess the role of F-FSPG PET/CT in intracranial malignancies. Materials and...
3.
Duan H, Baratto L, Hatami N, Liang T, Mari Aparici C, Davidzon G, et al.
Transl Oncol
. 2021 Nov;
15(1):101293.
PMID: 34823095
Objectives: Ga-PSMA11 PET/CT is excellent for evaluating biochemically recurrent prostate cancer (BCR PC). Here, we compared the positivity rates of dual-time point imaging using a PET/CT scanner (DMI) with silicon...
4.
Nakamoto R, Ferri V, Duan H, Hatami N, Goel M, Rosenberg J, et al.
Eur J Nucl Med Mol Imaging
. 2021 Nov;
50(1):184-193.
PMID: 34729628
Purpose: A novel cystine-knot peptide-based PET radiopharmaceutical, F-FP-R1-MG-F2 (knottin), was developed to selectively bind to human integrin αβ which is overexpressed in pancreatic cancer. The purpose of this study is...
5.
Duan H, Baratto L, Hatami N, Liang T, Levin C, Khalighi M, et al.
AJR Am J Roentgenol
. 2021 Aug;
218(2):333-340.
PMID: 34406051
Growing clinical adoption of PET/MRI for prostate cancer (PC) evaluation has increased interest in reducing PET/MRI scanning times. Reducing acquisition time per bed position below current times of at least...
6.
Baratto L, Toriihara A, Hatami N, Aparici C, Davidzon G, Levin C, et al.
Diagnostics (Basel)
. 2021 Jun;
11(6).
PMID: 34070751
We prospectively enrolled patients with neuroendocrine tumors (NETs). They underwent a single Ga-DOTA-TATE injection followed by dual imaging and were randomly scanned using first either the conventional or the silicon...
7.
Baratto L, Wu F, Minamimoto R, Hatami N, Liang T, Sabile J, et al.
Nucl Med Commun
. 2021 Mar;
42(7):792-799.
PMID: 33741852
Purpose: To determine if the correlation between different metabolic parameters along with clinical features can create an improved model of prognostication for diffuse large B-cell lymphoma (DLBCL) patients. Methods: We...
8.
Baratto L, Song H, Duan H, Hatami N, Bagshaw H, Buyyounouski M, et al.
J Nucl Med
. 2021 Mar;
62(11):1545-1549.
PMID: 33674398
Novel radiopharmaceuticals for PET are being evaluated for the diagnosis of biochemical recurrence (BCR) of prostate cancer (PC). We compared the gastrin-releasing peptide receptor-targeting Ga-RM2 with the prostate-specific membrane antigen...
9.
Nakamoto R, Harrison C, Song H, Guja K, Hatami N, Nguyen J, et al.
Mol Imaging Biol
. 2021 Jan;
23(4):614-623.
PMID: 33469884
Purpose: To evaluate the diagnostic performance and clinical utility of F-fluciclovine PET/CT in patients with biochemical recurrence (BCR) of prostate cancer (PC). Methods: F-Fluciclovine scans of 165 consecutive men with...
10.
Song H, Harrison C, Duan H, Guja K, Hatami N, Franc B, et al.
J Nucl Med
. 2019 Oct;
61(4):546-551.
PMID: 31628216
F-DCFPyL (2-(3-{1-carboxy-5-[(6-F-fluoropyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid) is a promising PET radiopharmaceutical targeting prostate-specific membrane antigen (PSMA). We present our experience with this single-academic-center prospective study evaluating the positivity rate of F-DCFPyL PET/CT in...